March 19, 2024

Indy Star interviewed Dr. Thomas F. Imperiale

Thomas Imperiale, MD

Indy Star interviewed Thomas F. Imperiale, M.D., about his study published in the New England Journal of Medicine. This next generation multi-target stool DNA colorectal cancer screening test detects 94 percent of colorectal cancers and has the best performance for detection of both colorectal cancer and advanced precancerous polyps of any noninvasive colorectal cancer screening test.

Read the IndyStar article
The Latest
Regenstrief Institute will host collaborative conference to improve public health data
News

Regenstrief Institute will host collaborative conference to improve public health data

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial
News

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial

Dr. Vachon on how partner satisfaction impacts breast cancer survivors’ well-being
Video

Dr. Vachon on how partner satisfaction impacts breast cancer survivors’ well-being

Call for Papers on Artificial Intelligence Applied to Pediatric Care
Influence

Call for Papers on Artificial Intelligence Applied to Pediatric Care

Dr. Maratt on closing screening gaps for colorectal cancer
Video

Dr. Maratt on closing screening gaps for colorectal cancer

Critical gap in colorectal cancer screening process: follow-up after positive stool test
News

Critical gap in colorectal cancer screening process: follow-up after positive stool test